Malignant Neoplasms Stated as Primary Lymphoid Haematopoietic

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB09053Ibrutinib0Not Yet Recruiting1
DB08870Brentuximab vedotin1Withdrawn1
DB00958Carboplatin1Recruiting1
DB01234Dexamethasone1Withdrawn1
DB06186Ipilimumab1Withdrawn1
DB00480Lenalidomide1Withdrawn1
DB09035Nivolumab1Withdrawn1
DB01229Paclitaxel1Recruiting1
DB11836Sapanisertib1Recruiting1
DB11836Sapanisertib1Withdrawn1
DB01008Busulfan1 / 2Not Yet Recruiting1
DB01008Busulfan1 / 2Recruiting1
DB00531Cyclophosphamide1 / 2Recruiting1
DB01234Dexamethasone1 / 2Not Yet Recruiting1
DB00099Filgrastim1 / 2Not Yet Recruiting1
DB00099Filgrastim1 / 2Recruiting1
DB01073Fludarabine1 / 2Recruiting1
DB00441Gemcitabine1 / 2Not Yet Recruiting1
DB00130L-Glutamine1 / 2Not Yet Recruiting1
DB01042Melphalan1 / 2Not Yet Recruiting1
DB00688Mycophenolate mofetil1 / 2Recruiting1
DB09074Olaparib1 / 2Not Yet Recruiting1
DB00039Palifermin1 / 2Not Yet Recruiting1
DB00165Pyridoxine1 / 2Not Yet Recruiting1
DB00073Rituximab1 / 2Not Yet Recruiting1
DB00398Sorafenib1 / 2Recruiting1
DB00864Tacrolimus1 / 2Recruiting1
DB02546Vorinostat1 / 2Not Yet Recruiting1
DB09052Blinatumomab2Recruiting1
DB00987Cytarabine2Recruiting1
DB09331Daratumumab2Withdrawn1
DB01234Dexamethasone2Recruiting1
DB09053Ibrutinib2Recruiting1
DB05889Inotuzumab ozogamicin2Recruiting1
DB00563Methotrexate2Recruiting1
DB09037Pembrolizumab2Recruiting1
DB06300Ponatinib2Recruiting1
DB08901Ponatinib2Recruiting1
DB08877Ruxolitinib2Recruiting1